BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19897574)

  • 21. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
    Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
    Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia.
    Abreu C; Moreno P; Palacios F; Borge M; Morande P; Landoni AI; Gabus R; Dighiero G; Giordano M; Gamberale R; Oppezzo P
    Leuk Lymphoma; 2013 Aug; 54(8):1844-8. PubMed ID: 23614796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
    J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
    PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.
    Hanoun M; Eisele L; Suzuki M; Greally JM; Hüttmann A; Aydin S; Scholtysik R; Klein-Hitpass L; Dührsen U; Dürig J
    PLoS One; 2012; 7(3):e34347. PubMed ID: 22470559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
    Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
    Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.
    Schmidt-Wolf IG; Plass C; Byrd JC; Frevel K; Pietsch T; Waha A
    Anticancer Res; 2016 Sep; 36(9):4515-9. PubMed ID: 27630290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique.
    Mohamad A; Hassan R; Husin A; Johan MF; Sulong S
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):85-91. PubMed ID: 33507683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
    Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
    Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
    Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
    Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients.
    Subhash S; Kanduri M
    J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential use of unmutated immunoglobulin heavy variable region genes in Boxer dogs with chronic lymphocytic leukemia.
    Rout ED; Burnett RC; Labadie JD; Yoshimoto JA; Avery AC
    PLoS One; 2018; 13(1):e0191205. PubMed ID: 29385200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
    Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
    Mansouri M; Sevov M; Fahlgren E; Tobin G; Jondal M; Osorio L; Roos G; Olivecrona G; Rosenquist R
    Leuk Res; 2010 Mar; 34(3):301-6. PubMed ID: 19709746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
    Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
    Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
    Rush LJ; Raval A; Funchain P; Johnson AJ; Smith L; Lucas DM; Bembea M; Liu TH; Heerema NA; Rassenti L; Liyanarachchi S; Davuluri R; Byrd JC; Plass C
    Cancer Res; 2004 Apr; 64(7):2424-33. PubMed ID: 15059895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
    Bomben R; Gobessi S; Dal Bo M; Volinia S; Marconi D; Tissino E; Benedetti D; Zucchetto A; Rossi D; Gaidano G; Del Poeta G; Laurenti L; Efremov DG; Gattei V
    Leukemia; 2012 Jul; 26(7):1584-93. PubMed ID: 22343732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia.
    Perkins B; Showel M; Schoch L; Imus PH; Karantanos T; Yonescu R; Morsberger L; Ghiaur G; Gladstone DE; Jones RJ
    Leuk Lymphoma; 2022 Jul; 63(7):1617-1623. PubMed ID: 35343368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.